[1]
“Study of Cardiovascular Toxicity of Selective COX-2 Inhibitors In Comparison With Conventional NSAIDs”, Int Jour of Biomed Res, vol. 7, no. 10, pp. 721–725, Nov. 2016, doi: 10.7439/ijbr.v7i10.3672.